Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial [2] (multiple letters)

American Journal of Ophthalmology

Volumn 128, Issue 5, 1999, Pages 662-663

  Akpek, E K ^a   Karadayl, K ^a   Cheetham, J K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

KETOROLAC TROMETAMOL;

CATARACT EXTRACTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; EYE INFLAMMATION; HUMAN; LETTER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA CYSTOID EDEMA; TOPICAL DRUG ADMINISTRATION;

EID: 0032705209     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)00333-5     Document Type: Letter

References (0)